Latest News

Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, has announced the appointment of two new directors to its board.

Melbourne-based precision medication management company Ward MM is partnering with US-based Endocanna Health on medicinal cannabis trials and related research in Australia.

Clinical research organisation Novotech has acquired Clinical Network Services (CNS) with the goal to expand services to the life sciences sector for early phase product development and clinical research through to later phase regional and global trials.

AusBiotech launched its diversity and inclusion statement today, as an important first step in a wider program of work, aimed at attracting the best and brightest talent from diverse backgrounds to biotech careers, and at fostering an inclusive industry culture.

The outgoing chair of CSL says the company is unlikely to undertake a share split given the cost and uncertain benefit.

The UK Biobank project is providing a first-of-its-kind resource for health researchers across the world to further medical research and drug development with the goal of developing more efficient personalised treatments for diseases.

Cook Medical Australia has been named the winner of the Premier of Queensland’s Export Award for Health and Biotechnology.

MTPConnect, the Medical Technologies and Pharmaceuticals Industry Growth Centre, has announced $690,000 in new funding for three projects.

A new report released today by the Association of Australian Medical Research Institutes (AAMRI), shows that for every dollar invested in Australian medical research, we gain a $3.90 return to the economy.

Labor has introduced a bill to parliament it says is designed to provide safeguards against a government negotiating changes to a range of programs and policies, including the PBS, as part of a future trade agreement.

Cochlear (ASX:COH) has announced the next phase in its R&D program that it hopes will lead to a totally implantable cochlear implant.

AbbVie hosted a 'Cancer Moonshot Seminar' for the American Chamber of Commerce’s Innovation Committee in Sydney earlier this week.